George Clinical CMO, Maria Ali, and Emily Todd will be attending. We would love to arrange a time to connect and discuss how we can support your needs and explore potential collaborations. If you'll be there, reach out to Emily ([email protected]) to schedule a meeting. Looking forward to seeing you in Boston! #ScienceServiceSolutions #ImprovingHealthWorldwide #NooneLeftBehind #ClinicalTrials #MASH2024
George Clinical
Pharmaceutical Manufacturing
Sydney, NSW 105,102 followers
Science. Service. Solutions.
About us
George Clinical is a leading global clinical research organization founded in Asia-Pacific driven by scientific expertise and operational excellence. With over 20 years of experience and more than 500 people managing 40 geographical locations throughout the Asia-Pacific region, USA and Europe, George Clinical provides the full range of clinical trial services to biopharmaceutical, medical device, and diagnostic customers, for all trial phases, registration, and post-marketing trials. Stay up to date on the latest clinical research news, case studies and perspectives from George Clinical thought leaders by signing up for our monthly e-newsletter. georgeclinical.com/subscribe/newsletter
- Website
-
http://www.georgeclinical.com
External link for George Clinical
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Sydney, NSW
- Type
- Privately Held
- Founded
- 2000
- Specialties
- Clinical Trials, CRO, Scientific Leadership, Asia Pacific, Data Management, Clinical Operations, Diabetes, Cardiovascular, Stroke, Respiratory, Oncology, Medical Devices, Epidemiology, Endpoint Adjudication, Site Management, Regulatory Submissions, Project Management, Renal, Kidney & Metabolic, Early Phase, Pharmacovigilance, CGT, and Cell Gene Therapy
Locations
Employees at George Clinical
Updates
-
George Clinical reposted this
Our 3rd simultaneous publication for European Society of Cardiology #ESCCongress Pooled individual participant data from ~15,000 patients in 4 large-scale randomized trials examining the relationship between NT-proBNP, kidney function & outcomes in #HFpEF For any given NT-proBNP concentration, the absolute risk of adverse outcomes is substantial higher for people with reduced kidney function, compared to those with preserved kidney function. Bottom line: These data call into question proposals for higher NT-proBNP references ranges in people with #CKD, and suggest that reduced kidney function per se should not be a reason to disregard higher NT-proBNP levels. Read the full details in the American College of Cardiology's JACC-HF: https://lnkd.in/ewSkuCAf
-
George Clinical reposted this
We’re all set for the European Society of Cardiology Congress taking place in London from Friday 30 August until Monday 2 September. And we’re delighted that on Saturday 31 August, our Chief Medical Officer Anthony Rodgers, will be joining a Hot Line Session to present results from our two international Phase III trials investigating #GMRx2, George Medicines’ novel, multi-mechanism triple combination candidate for the treatment of #hypertension, including initiation of treatment. Find out more here: https://lnkd.in/eqwUes4J We look forward to seeing you there! #GeorgeMedicines #ESCCongress #presentation #conference
-
Scientific Leadership Brendon L Neuen
Our first simultaneous publication for the #ESCCongress in London now online in Circulation: In a meta-analysis of Harmony Outcomes, AMPLITUDE-O and FLOW trials, the benefits of #GLP1 receptor agonists on cardiovascular and kidney outcomes were independent of #SGLT2 inhibitor use - These data represent the most comprehensive assessment of the effects of GLP-1 receptor agonists on clinical outcomes in people with #diabetes, with and without SGLT2 inhibitors, and support the use of both agents in combination to improve cardio-renal outcomes. Read the full text: https://lnkd.in/dNg9z73S #type2diabetes #semaglutide #ozempic #obesity #kidneyGDMT #4pillarsCKD
-
Do you know the scientific leader guiding your study? The right expertise can make all the difference in your trial's success. Learn more about one of George Clinical's, Ari VanderWalde. #ScienceServiceSolutions #ImprovingHealthWorldwide #NooneLeftBehind #ClinicalTrials #Oncology
-
Want to talk to the leading global CRO in kidney and metabolic research? George Clinical will have global team members and internationally recognized scientific leaders in attendance at Kidney Week. Reach out to Dan Gallagher to schedule a meeting. We will be at booth #721. Stop by and learn about our world-class therapeutic expertise and our Global Kidney Patients Trial Network (GKPTN). #ScienceServiceSolutions #ImprovingHealthWorldwide #NooneLeftBehind #ClinicalTrials #KidneyWeek
-
Want help with the strategic implementation of your clinical pipeline? Rachel Condjella, Oncology Portfolio Director, will be at #ESMO2024 to answer your questions. Set up a time to meet to discuss: • Our expertise in FIH PI-III oncology trials • Our global network of oncology KOLs • How we can ensure successful execution and completion of your clinical assets See you there! #ScienceServiceSolutions #ImprovingHealthWorldwide #NooneLeftBehind #ClinicalTrials #oncology
-
George Clinical reposted this
Scientific Leadership Ben Talbot
-
We celebrate the researchers who work every day to improve the lives of breast cancer patients everywhere. #ScienceServiceSolutions #ImprovingHealthWorldwide #NooneLeftBehind #ClinicalTrials #Research